Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LBX Pharmacy Chain JSC's Other Operating Expense for the
three
months ended in Mar. 2026 was ¥5 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ¥3,908 Mil.
LBX Pharmacy Chain JSC's quarterly Other Operating Expense
increased
from Sep. 2025 (¥-1,910 Mil) to Dec. 2025 (¥3,905 Mil) but then
declined
from Dec. 2025 (¥3,905 Mil) to Mar. 2026 (¥5 Mil).
LBX Pharmacy Chain JSC's annual Other Operating Expense
increased
from Dec. 2023 (¥3,697 Mil) to Dec. 2024 (¥4,069 Mil) but then
declined
from Dec. 2024 (¥4,069 Mil) to Dec. 2025 (¥3,906 Mil).
LBX Pharmacy Chain JSC Other Operating Expense Related Terms
LBX Pharmacy Chain JSC Other Operating Expense Historical Data
* Premium members only.
The historical data trend for LBX Pharmacy Chain JSC's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LBX Pharmacy Chain JSC Other Operating Expense Chart
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,908 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of ¥3,908 Mil mean?
LBX Pharmacy Chain JSC (SHSE:603883) has a Other Operating Expense of ¥3,908 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on LBX Pharmacy Chain JSC and its competitors.
Is LBX Pharmacy Chain JSC's Other Operating Expense too high?
LBX Pharmacy Chain JSC's current Other Operating Expense is ¥3,908 Mil. Overall, LBX Pharmacy Chain JSC has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does LBX Pharmacy Chain JSC's Other Operating Expense compare to competitors?
LBX Pharmacy Chain JSC's Other Operating Expense of ¥3,908 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on LBX Pharmacy Chain JSC and its competitors. LBX Pharmacy Chain JSC's current Other Operating Expense is ¥3,908 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LBX Pharmacy Chain JSC stock overvalued right now?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC (SHSE:603883) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥19.42, compared to a current price of ¥12.87 — trading 33.7% below its estimated fair value. The current Other Operating Expense is ¥3,908 Mil. LBX Pharmacy Chain JSC's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For LBX Pharmacy Chain JSC (SHSE:603883), the current Other Operating Expense is ¥3,908 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LBX Pharmacy Chain JSC (SHSE:603883) Overvalued in 2026?
Based on GuruFocus' analysis, LBX Pharmacy Chain JSC stock appears to be undervalued.
The current stock price of ¥12.87 is trading 33.7% below its estimated GF Value™ of ¥19.42.
GuruFocus considers LBX Pharmacy Chain JSC to be Significantly Undervalued.
Key valuation signals for SHSE:603883:
Other Operating Expense: ¥3,908 Mil
GF Value™: ¥19.42 vs. price of ¥12.87 (33.7% below fair value)
No single metric tells the full story. See the SHSE:603883 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LBX Pharmacy Chain JSC is a China-based company engages in the sale of medicine and health products. The company is engaged in retailing drugs and other related products, including Chinese and Western medicine, prepared slices of Chinese crude drugs, health equipment, healthy food, and personal care products and life care products. The company is also involved in the wholesale and manufacture of drugs.
80GF Score
Get the complete analysis for SHSE:603883
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603883 has been successfully added to your 
